AKT1 and breast carcinoma: This study is the first time that we have confirmed that a decline in AKT phosphorylation may suppress cell proliferation and invasion in an AQP5 knockout ES cell model, which also provides a theoretical basis for the enhanced biological effects of AQP5 over-expression in other types of cells, such as breast cancer and lung cancer cells [27–30].